Skip to main content
. 2017 Oct 19;21:252. doi: 10.1186/s13054-017-1849-0

Fig. 1.

Fig. 1

Forest plot depicting analysis of the risk of mortality at longest follow-up in patients treated with levosimendan vs placebo. LVEF Left ventricular ejection fraction, LCOS Low cardiac output syndrome, M-H Mantel-Haenszel